0000950170-24-064095.txt : 20240523
0000950170-24-064095.hdr.sgml : 20240523
20240523180006
ACCESSION NUMBER: 0000950170-24-064095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240522
FILED AS OF DATE: 20240523
DATE AS OF CHANGE: 20240523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chartier Kirk
CENTRAL INDEX KEY: 0001483333
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35503
FILM NUMBER: 24980049
MAIL ADDRESS:
STREET 1: C/O OPTIONSXPRESS HOLDINGS, INC.
STREET 2: 311 WEST MONROE; SUITE 1000
CITY: CHICAGO
STATE: IL
ZIP: 60606
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enova International, Inc.
CENTRAL INDEX KEY: 0001529864
STANDARD INDUSTRIAL CLASSIFICATION: PERSONAL CREDIT INSTITUTIONS [6141]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 453190813
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 WEST JACKSON BLVD.
STREET 2: SUITE 600
CITY: CHICAGO
STATE: IL
ZIP: 60604
BUSINESS PHONE: 312-568-4200
MAIL ADDRESS:
STREET 1: 175 WEST JACKSON BLVD.
STREET 2: SUITE 600
CITY: CHICAGO
STATE: IL
ZIP: 60604
4
1
ownership.xml
4
X0508
4
2024-05-22
0001529864
Enova International, Inc.
ENVA
0001483333
Chartier Kirk
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 600
CHICAGO
IL
60604
false
true
false
false
Chief Strategy Officer
false
Common stock, par value $0.00001 per share
2024-05-22
4
M
false
30819
20.85
A
158725
D
Common stock, par value $0.00001 per share
2024-05-22
4
S
false
30819
60.1571
D
127906
D
Common stock, par value $0.00001 per share
2024-05-22
4
S
false
10484
60.1517
D
117422
D
Non-Qualified Stock Option (right to buy) with limited SAR
20.85
2024-05-22
4
M
false
30819
0
D
2025-02-13
Common stock; par value $0.00001 per share
30819
0
D
This transaction was executed in multiple trades at prices ranging from $59.84 to $61.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $59.85 to $60.99. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.
The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
The options vested in substantially equal one-third increments on each of the following dates: February 13, 2019, February 13, 2020 and February 13, 2021.
Reflects the number of shares underlying unexercised options solely with respect to the Reporting Person's February 13, 2018 stock option award.
/s/ Sean Rahilly, as attorney in fact
2024-05-23